Per Protocol Analysis

Per Protocol Analysis - Axcellant

Per Protocol Analysis

  1. lut 28, 2025

What Does the 'Per Protocol Analysis’ Mean?

Per Protocol Analysis is a method of analyzing clinical trial data that includes only participants who fully complied with the study protocol. This approach focuses on evaluating the treatment effect under ideal conditions, considering only those subjects who adhered to all aspects of the trial design. It excludes participants who deviated from the protocol, such as those who dropped out or did not follow the prescribed intervention.

The primary purpose of Per Protocol Analysis is to assess the efficacy of a treatment when administered exactly as intended. While this method can provide insights into the maximum potential benefit of an intervention, it may not reflect real-world effectiveness due to its selective nature. Per Protocol Analysis is often conducted alongside Intent-to-Treat analysis to provide a comprehensive understanding of trial results.

Why Is the 'Per Protocol Analysis’ Important in Clinical Research?

Per Protocol Analysis is crucial in clinical research as it provides a measure of the maximum potential efficacy of a treatment under optimal conditions. This approach helps researchers understand how well an intervention works when administered exactly as intended, which can be valuable for regulatory submissions and determining the best-case scenario for treatment outcomes.

Additionally, Per Protocol Analysis serves as a complementary method to Intent-to-Treat analysis, offering a more complete picture of trial results. By comparing findings from both analyses, researchers can gain insights into the impact of protocol deviations and non-adherence on treatment effectiveness, which is essential for interpreting and generalizing study results to real-world clinical practice.

Good Practices and Procedures

  1. Clearly define protocol deviation criteria and adherence thresholds in the statistical analysis plan before unblinding the study data.
  2. Conduct sensitivity analyses using different adherence cutoffs to assess the robustness of the Per Protocol results.
  3. Document and report all reasons for exclusion from the Per Protocol population to maintain transparency.
  4. Compare baseline characteristics between the Per Protocol and Intent-to-Treat populations to identify potential selection bias.
  5. Consider using statistical methods, such as inverse probability weighting, to adjust for potential confounding in the Per Protocol analysis.

Related Terms

Read more

Axcellant partners with Prometheus MedTech.AI to accelerate AI-powered cardiac diagnostics

We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…

Axcellant at EANM 2025: What We Brought Back from Barcelona

The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…

Radioisotopes in Medicine: Clinical Applications, Safety, and Regulatory Considerations

The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…